The course of hyperinsulinism related to the GCK mutation might vary from a mild form of hypoglycemia, which can be managed with diazoxide as reported in most cases, to a severe clinical phenotype of uncontrollable hypoglycemia leading to death [13]. This evidence concerns the gene GCK and hyperinsulinism.